AstraZeneca therapy for clearing protein deposits fails main goal in late-stage study
By Pushkala Aripaka (Reuters) -AstraZeneca's experimental therapy anselamimab did not meet the main goal of a late-stage study for the ...
Read moreDetailsBy Pushkala Aripaka (Reuters) -AstraZeneca's experimental therapy anselamimab did not meet the main goal of a late-stage study for the ...
Read moreDetails
